Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue Frontiers in Medicine Année : 2022

Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report

Résumé

IntroductionPosterior reversible encephalopathy syndrome (PRES) is a rare neurological disorder caused by the dysregulation of cerebral perfusion. Case PresentationWe report on a 18-year-old female patient with a history of end-stage renal disease and thrice weekly hemodialysis. She was admitted to the emergency department with mental confusion, blurred vision, headaches, and vomiting, following self-medication with an oral decongestant containing pseudoephedrine. We observed hypointense lesions with T1-weighted MRI and hyperintense areas with T2-weighted and fluid-attenuated inversion recovery MRI sequences. The lack of diffusion restriction was consistent with a diagnosis of PRES. A concomitant Enterobacter cloacae hemodialysis catheter-bloodstream infection was also diagnosed. We hypothesize that both sepsis and inappropriate self-medication with oral pseudoephedrine contributed to hypertension, endothelial dysfunction, and vasogenic edema. The patient received intensive care and made a full recovery. DiscussionPRES is a life-threatening condition that requires intensive care. Identification of the etiology is the keystone of medical care. Inappropriate self-medication with an oral decongestant might trigger PRES - highlighting the importance of patient education.

Dates et versions

hal-03647955 , version 1 (21-04-2022)

Identifiants

Citer

Clement Brault, Yoann Zerbib, Louis Gibert, Youssef Bennis, Kamel Masmoudi, et al.. Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report. Frontiers in Medicine, 2022, 9, ⟨10.3389/fmed.2022.837324⟩. ⟨hal-03647955⟩

Collections

U-PICARDIE MP3CV
9 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More